Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639]

BACKGROUND: Coronary artery disease remains the dominant cause of mortality in developed countries. While platelets have been recognized to play a pivotal role in atherothrombosis, the ideal antiplatelet regime after coronary artery surgery remains elusive. The evolution of CABG has presently moved...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasparovic, Hrvoje, Petricevic, Mate, Kopjar, Tomislav, Djuric, Zeljko, Svetina, Lucija, Biocina, Bojan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502596/
https://www.ncbi.nlm.nih.gov/pubmed/22920307
http://dx.doi.org/10.1186/1745-6215-13-148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502596/
https://www.ncbi.nlm.nih.gov/pubmed/22920307
http://dx.doi.org/10.1186/1745-6215-13-148

Ejemplares similares